日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Advanced stage melanoma during pregnancy: recommendations from a retrospective, multicentre, registry-based study

妊娠期晚期黑色素瘤:一项回顾性、多中心、基于登记研究的建议

Borgers, Jessica S W; Johnson, Douglas B; Livingstone, Elisabeth; Schadendorf, Dirk; Buchbinder, Elizabeth I; Haydu, Lauren E; Gohil, Laura; Robinson, William A; Mehmi, Inderjit; Hamid, Omid; Ferreira, Michelle; Salama, April K S; Dimitriou, Florentia; Carlino, Matteo S; Long, Georgina V; Ascierto, Paolo A; Simeone, Ester; Najjar, Yana G; Hospers, Geke A P; Choi, Jacob; Chandra, Sunandana; Wayne, Jeffrey D; García, Carlos I R; Xu, Wen; Lebbé, Céleste; Da-Meda, Laetitia; Atkinson, Victoria; Mckean, Meredith; Forschner, Andrea; Asare, Elliot A; Daletzakis, Antonios; Taylor, Jolyn S; Amant, Frédéric; Tsai, Katy K; Eroglu, Zeynep; Haanen, John B A G; Glitza de Oliva, Isabella C

Soluble CD27 differentially predicts resistance to anti-PD1 alone but not with anti-CTLA-4 in melanoma.

可溶性 CD27 可预测黑色素瘤对单独使用抗 PD-1 疗法的耐药性,但不能预测对同时使用抗 CTLA-4 疗法的耐药性

Sam Ikuan, Benhamouda Nadine, Biard Lucie, Da Meda Laetitia, Desseaux Kristell, Baroudjan Barouyr, Nakouri Ines, Renaud Marion, Sadoux Aurélie, Alkatrib Marina, Deleuze Jean-François, Battistella Maxime, Shen Yimin, Resche-Rigon Matthieu, Mourah Samia, Lebbe Celeste, Tartour Eric

Telomere-Associated Changes in Nuclear Architecture of Cancer-Associated Macrophage-like Cells in Liquid Biopsies from Melanoma Patients

黑色素瘤患者液体活检中癌相关巨噬细胞样细胞核结构的端粒相关变化

Rangel-Pozzo, Aline; Wechsler, Janine; Groult, Jessica; Da Meda, Laetitia; Lebbe, Celeste; Mai, Sabine

Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection

免疫检查点抑制剂可增强 SARS-CoV-2 感染期间的 T 细胞免疫力

Nader Yatim, Jeremy Boussier, Pauline Tetu, Nikaïa Smith, Timothée Bruel, Bruno Charbit, Laura Barnabei, Aurélien Corneau, Laetitia Da Meda, Clara Allayous, Barouyr Baroudjian, Majdi Jebali, Florian Herms, Ludivine Grzelak, Isabelle Staropoli, Vincent Calmettes, Jerome Hadjadj, Olivier Peyrony, Char

Baseline Genomic Features in BRAFV600-Mutated Metastatic Melanoma Patients Treated with BRAF Inhibitor + MEK Inhibitor in Routine Care

接受 BRAF 抑制剂 + MEK 抑制剂常规治疗的 BRAFV600 突变转移性黑色素瘤患者的基线基因组特征

Baptiste Louveau, Fanelie Jouenne, Coralie Reger de Moura, Aurelie Sadoux, Barouyr Baroudjian, Julie Delyon, Florian Herms, Adele De Masson, Laetitia Da Meda, Maxime Battistella, Nicolas Dumaz, Celeste Lebbe, Samia Mourah

Occurrence of type 1 and type 2 diabetes in patients treated with immunotherapy (anti-PD-1 and/or anti-CTLA-4) for metastatic melanoma: a retrospective study

接受免疫疗法(抗PD-1和/或抗CTLA-4)治疗的转移性黑色素瘤患者中1型和2型糖尿病的发生情况:一项回顾性研究

Gauci, Marie-Léa; Boudou, Philippe; Baroudjian, Barouyr; Vidal-Trecan, Tiphaine; Da Meda, Laetitia; Madelaine-Chambrin, Isabelle; Basset-Seguin, Nicole; Bagot, Martine; Pages, Cécile; Mourah, Samia; Resche-Rigon, Matthieu; Pinel, Sylvine; Sassier, Marion; Rouby, Franck; Eftekhari, Pirayeh; Lebbé, Céleste; Gautier, Jean-François

Clinical value of early detection of circulating tumour DNA-BRAF(V600mut) in patients with metastatic melanoma treated with a BRAF inhibitor

早期检测循环肿瘤DNA-BRAF(V600mut)在接受BRAF抑制剂治疗的转移性黑色素瘤患者中的临床价值

Louveau, Baptiste; Tost, Jörg; Mauger, Florence; Sadoux, Aurélie; Podgorniak, Marie-Pierre; How-Kit, Alexandre; Pages, Cécile; Roux, Jennifer; Da Meda, Laetitia; Lebbe, Céleste; Mourah, Samia